By sustaining glycolysis, HIF1α maintains [acetyl-CoA], IFN-γ induction, tumor-killing ability of hypoxic T cells, and tumor responses to ICB, identifying loss of HIF1α as a major T cell-intrinsic mechanism of ICB resistance, which can be overcome by acetate supplementation. The gene discussed is IFNG; the disease is neoplasm.